Zoladex 3,6 mg (Orifarm) implant s.c. pre-filled syr.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Goserelin Acetate - Eq. Goserelin 3,6 mg
Available from:
Orifarm a.s.
ATC code:
L02AE03
Pharmaceutical form:
Implant
Administration route:
Subcutaneous use
Therapeutic area:
Goserelin
Product summary:
CTI Extended: 588462-01
Authorization status:
Commercialised: No
Authorization date:
2021-08-12
